CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
Diabetes Metab J. 2021;45(2):251-259.   Published online March 5, 2021
DOI: https://doi.org/10.4093/dmj.2020.0206

Excel Download

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
Guntram Schernthaner
Diabetes & Metabolism Journal. 2021;45(4):615-616   Crossref logo
Link1 Link2 Link3
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
Sang Youl Rhee
Diabetes & Metabolism Journal. 2021;45(4):619-620   Crossref logo
Link1 Link2 Link3
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
Diabetes & Metabolism Journal. 2021;45(2):251-259   Crossref logo
Link1 Link2 Link3
The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer’s disease
Ahmet Turan Isik, Pinar Soysal, Adnan Yay, Cansu Usarel
Diabetes Research and Clinical Practice. 2017;123:192-198   Crossref logo
Link1 Link2
Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands
Rick I. Meijer, Trynke Hoekstra, Niels C. Gritters van den Oever, Suat Simsek, Joop P. van den Bergh, Renée A. Douma, Auke C. Reidinga, Hazra S. Moeniralam, Tom Dormans, Mark M. Smits,
Journal of Diabetes & Metabolic Disorders. 2021;   Crossref logo
Link1 Link2 Link3
Association Between DPP-4 Inhibitors and COVID-19–Related Outcomes Among Patients With Type 2 Diabetes
Yunha Noh, In-Sun Oh, Han Eol Jeong, Kristian B. Filion, Oriana Hoi Yun Yu, Ju-Young Shin
Diabetes Care. 2021;44(4):e64-e66   Crossref logo
Link1
Efficacy and safety of once-weekly GLP-1 RA in patients with type 2 diabetes treated with DPP-4 inhibitor
Masako Murakami, Naoko Hirahara, Hiroshi Morita, Shigekazu Sasaki
Diabetes Research and Clinical Practice. 2016;120:S105   Crossref logo
Link1 Link2
Retinal outcomes of COVID-19: Possible role of CD147 and cytokine storm in infected patients with diabetes mellitus
Ícaro Raony, Camila Saggioro de Figueiredo
Diabetes Research and Clinical Practice. 2020;165:108280   Crossref logo
Link1 Link2
Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients
Julie M. Shabto, Leah Loerinc, Ghazala A. O'Keefe, James O'Keefe
Diabetes Research and Clinical Practice. 2020;164:108229   Crossref logo
Link1 Link2
Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
Nina A. Petunina, Anna L. Terekhova, Ekaterina V. Goncharova
Diabetes mellitus. 2016;19(6):511-517   Crossref logo
Link1 Link2